Trexquant Investment LP acquired a new stake in Viemed Healthcare, Inc. (NASDAQ:VMD - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 58,346 shares of the company's stock, valued at approximately $468,000. Trexquant Investment LP owned approximately 0.15% of Viemed Healthcare at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. National Bank of Canada FI increased its stake in Viemed Healthcare by 91.2% during the 3rd quarter. National Bank of Canada FI now owns 3,346 shares of the company's stock worth $25,000 after buying an additional 1,596 shares during the period. Barclays PLC raised its stake in shares of Viemed Healthcare by 342.3% in the third quarter. Barclays PLC now owns 53,439 shares of the company's stock valued at $392,000 after acquiring an additional 41,358 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in Viemed Healthcare by 151.7% in the third quarter. JPMorgan Chase & Co. now owns 98,798 shares of the company's stock valued at $724,000 after purchasing an additional 59,538 shares during the period. SG Americas Securities LLC grew its stake in Viemed Healthcare by 193.1% during the 4th quarter. SG Americas Securities LLC now owns 35,579 shares of the company's stock worth $285,000 after purchasing an additional 23,442 shares in the last quarter. Finally, R Squared Ltd purchased a new stake in Viemed Healthcare during the 4th quarter worth about $41,000. Hedge funds and other institutional investors own 74.24% of the company's stock.
Viemed Healthcare Stock Up 0.3 %
Shares of VMD traded up $0.02 during midday trading on Tuesday, hitting $6.61. The company had a trading volume of 106,443 shares, compared to its average volume of 137,146. Viemed Healthcare, Inc. has a 1 year low of $6.21 and a 1 year high of $9.81. The firm has a market capitalization of $261.24 million, a P/E ratio of 24.48 and a beta of 1.64. The company has a debt-to-equity ratio of 0.03, a quick ratio of 1.19 and a current ratio of 1.31. The company's 50-day simple moving average is $7.44 and its 200-day simple moving average is $8.14.
Viemed Healthcare Profile
(
Free Report)
Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.
Further Reading
Before you consider Viemed Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Viemed Healthcare wasn't on the list.
While Viemed Healthcare currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
